- Home
- INO vs STHO Comparison
INO vs STHO Comparison
Compare INO & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | STHO |
|---|---|---|
| Founded | 1979 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 102.0M |
| IPO Year | 1999 | 2022 |
Fundamental Metrics
Financial Performance| Metric | INO | STHO |
|---|---|---|
| Price | $1.34 | $8.67 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 17.2K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | 24.73 |
| EPS | N/A | ★ N/A |
| Revenue | $42,220,086.00 | ★ $110,143,000.00 |
| Revenue This Year | $20,156.19 | N/A |
| Revenue Next Year | $421.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.03 | $6.06 |
| 52 Week High | $2.86 | $9.24 |
Technical Indicators
Market Signals| Indicator | INO | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 54.70 | 57.85 |
| Support Level | $1.03 | $8.21 |
| Resistance Level | $1.52 | $9.16 |
| Average True Range (ATR) | 0.12 | 0.22 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 35.51 | 64.24 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.